These findings suggest that the modulation of N-myristoylation under hypoxic conditions could be a key factor in the therapeutic landscape of HNSCC, especially considering the critical role of N-myristoylation and the design of novel strategies involving PD-L1 membrane localization in immune suppression. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.